Eculizumab in rapidly progressive glomerulonephritis: a case-series report
ObjectiveTo describe the clinical outcomes and safety profile of eculizumab as adjunctive therapy in a case series of patients with rapidly progressive glomerulonephritis (RPGN) due to anti-glomerular basement membrane (GBM) disease and anti-neutrophil…